Criminal Code Act 1995

Schedule - The Criminal Code  

Section 3

CHAPTER 9 - DANGERS TO THE COMMUNITY  

Part 9.1 - Serious drug offences  

Division 314 - (Repealed by No 167 of 2012)  

SECTION 314.4   Border controlled drugs  

(1)  


The following table lists border controlled drugs and sets out quantities:


Controlled precursors and quantities
Controlled precursor Marketable Commercial
quantity quantity
(grams) (grams)
1     Acetorphine 2.0 2.0
2     Acetyl-alpha-methylfentanyl 0.005 0.005
3     Acetylcodeine 2.0 2.0
4     Acetyldihydrocodeine 2.0 2.0
5     Acetylmethadol 2.0 2.0
6     Allylprodine 2.0 2.0
7     Alphacetylmethadol 10.0 10.0
8     Alphameprodine 0.2 0.2
9     Alphamethadol 0.2 0.2
10   alpha-Methylfentanyl 0.005 0.005
11   alpha-Methylthiofentanyl 0.005 0.005
12   Alphaprodine 25.0 25.0
13   Amphecloral 2.0 2.0
14   3-(2-Aminopropyl)indole (alpha-methyltryptamine (AMT)) 2.0 2.0
15   Amphetamine 2.0 0.75
16   Anileridine 25.0 25.0
17   Barbiturates 50.0 5.0
18   Benzethidine 10.0 10.0
19   Benzoylecgonine 2.0 2.0
20   Benzylmorphine 5.0 5.0
20A   Benzylpiperazine (BZP) 2.0 0.75
21   Betacetylmethadol 5.0 5.0
22   beta-Hydroxyfentanyl 0.005 0.005
23   beta-Hydroxy-3-methylfentanyl 0.005 0.005
24   Betameprodine 5.0 5.0
25   Betamethadol 5.0 5.0
26   Betaprodine 5.0 5.0
27   Bezitramide 5.0 5.0
28   4-Bromo-2,5-dimethoxy amphetamine 0.5 0.5
29   Bufotenine 2.0 2.0
30   Cannabinoids (other than a Cannabinoid of a kind that can be obtained from a plant that is not a Cannabis plant) 2.0 2.0
31   Cannabis (in any form, including flowering or fruiting tops, leaves, seeds or stalks, but not including Cannabis resin or Cannabis fibre) 25,000.0 100.0
32   Cannabis resin 20.0 50.0
33   Chlorophentermine 2.0 2.0
34   Clonitazene 5.0 5.0
35   Cocaine 2.0 2.0
36   Codeine 10.0 10.0
37   Codeine-N-oxide 10.0 10.0
38   Codoxime 10.0 10.0
39   Desomorphine 2.0 2.0
40   Dexamphetamine 2.0 2.0
41   Dextromoramide 2.0 2.0
42   2,5-Dimethoxy-4-n-propylthiophenethylamine (2C-T-7) 0.5 0.5
43   2,5-Dimethoxy-4-ethylthiophenethylamine (2C-T-2) 0.5 0.5
44   2,5-Dimethoxy-4-iodophenethylamine (2C-I) 0.5 0.5
45   Diampromide 5.0 5.0
46   Diethylpropion 5.0 5.0
47   Diethylthiambutene 5.0 5.0
48   N,N-Diethyltryptamine 2.0 2.0
49   Difenoxin 2.0 2.0
50   Dihydrocodeine 10.0 10.0
51   Dihydromorphine 10.0 10.0
52   Dimenoxadol 10.0 10.0
53   Dimepheptanol 10.0 10.0
54   2,5-Dimethoxy-4-methyl amphetamine 2.0 0.75
55   1-Dimethylamino-1,2-diphenyl ethane 5.0 5.0
56   Dimethylthiambutene 20.0 20.0
57   N,N-Dimethyltryptamine 2.0 2.0
58   Dioxaphetyl butyrate 2.0 2.0
59   Diphenoxylate 2.0 2.0
60   Dipipanone 10.0 10.0
61   Drotebanol 2.0 2.0
62   Ecgonine 10.0 10.0
63   Ethchlorvynol 50.0 50.0
64   Ethinamate 50.0 50.0
65   Ethylmethylthiambutene 10.0 10.0
66   Ethylmorphine 2.0 2.0
67   Etonitazene 5.0 5.0
68   Etorphine 5.0 5.0
69   Etoxeridine 5.0 5.0
70   Fentanyl 0.005 0.005
71   Furethidine 1.0 1.0
72   Gammabutyrolactone (GBL) 2.0 1.0
73   Glutethimide 50.0 50.0
74   Harmaline 2.0 5.0
75   Harmine 2.0 5.0
76   Heroin (diacetylmorphine) 2.0 1.5
77   Hydrocodone 2.0 2.0
78   Hydromorphinol 2.0 2.0
79   Hydromorphone 2.0 2.0
80   Hydroxyamphetamine 2.0 2.0
81   4-Hydroxybutanoic acid (GHB) 2.0 1.0
82   Hydroxypethidine 5.0 5.0
83   Isomethadone 2.0 2.0
83A   Ketamine 3.0 1.0
84   Ketobemidone 2.0 2.0
85   Levophenacylmorphan 2.0 2.0
86   Levomethorphan, but not including dextromethorphan 2.0 2.0
87   Levorphanol, but not including dextrorphan 1.0 1.0
88   Lysergamide 0.1 0.01
89   Lysergide (LSD) 0.002 0.002
90   Meprobamate 50.0 50.0
91   Mescaline 7.5 7.5
92   Metazocine 7.0 7.0
93   Methadone 2.0 2.0
93A   Methamphetamine 2.0 0.75
94   Methaqualone 50.0 5.0
95   Methcathinone 2.0 0.75
96   Methorphan, but not including dextromethorphan 2.0 2.0
97   5-Methoxy-alpha-methyltrypt amine (5-MeO-AMT) 2.0 2.0
98   5-Methoxy-N,N-diisopropyl tryptamine (5-MeO-DiPT) 2.0 2.0
99   (Repealed by No 24 of 2012)
100   3,4-Methylenedioxyamphetamine (MDA) 0.5 0.75
101   3,4-Methylenedioxymethamphet amine (MDMA) 0.5 0.5
102   Methyldesorphine 2.0 2.0
103   Methyldihydromorphine 2.0 2.0
104   3-Methylfentanyl 0.005 0.005
104A   4-Methylmethcathinone (4-MMC) 2.0 0.75
105   Methylphenidate 2.0 2.0
106   1-Methyl-4-phenyl-4-propion oxypiperidine (MPPP) 2.0 2.0
107   3-Methylthiofentanyl 0.005 0.005
108   Methyprylon 50.0 50.0
109   Metopon 2.0 2.0
110   Monoacetylmorphines 2.0 2.0
111   Moramide 2.0 2.0
112   Morphan, but not including dextrorphan 2.0 2.0
113   Morpheridine 2.0 2.0
114   Morphine 2.0 1.5
115   Morphine-N-oxide 2.0 2.0
116   Myrophine 20.0 20.0
117   Nicocodine 2.0 2.0
118   Nicodicodine 2.0 2.0
119   Nicomorphine 2.0 2.0
120   Noracymethadol 2.0 2.0
121   Norcodeine 2.0 2.0
122   Norlevorphanol 2.0 2.0
123   Normethadone 5.0 5.0
124   Normorphine 20.0 20.0
125   Norpipanone 10.0 10.0
126   Opium 20.0 20.0
127   Oxycodone 5.0 5.0
128   Oxymorphone 2.0 2.0
129   para-Fluorofentanyl 0.005 0.005
130   Pentazocine 20.0 20.0
131   Pethidine 10.0 10.0
132   Phenadoxone 10.0 10.0
133   Phenampromide 10.0 10.0
134   Phenazocine 1.0 1.0
135   Phencyclidine 2.0 2.0
136   Phendimetrazine 5.0 5.0
137   Phenmetrazine 5.0 5.0
138   Phenomorphan 5.0 5.0
139   Phenoperidine 1.0 1.0
140   Phentermine 5.0 5.0
141   1-Phenylethyl-4-phenyl-4-ace toxypiperidine (PEPAP) 2.0 2.0
142   Pholcodine 5.0 5.0
143   Piminodine 10.0 10.0
144   Pipradrol 1.0 1.0
145   Piritramide 1.0 1.0
146   Proheptazine 1.0 1.0
147   Properidine 25.0 25.0
148   Propiram 10.0 10.0
149   Psilocine 0.1 0.1
150   Psilocybine 0.1 0.1
151   Tetrahydrocannabinols 2.0 5.0
152   Thebacon 2.0 2.0
153   Thebaine 2.0 2.0
154   Thiofentanyl 0.005 0.005
155   Trimeperidine 10.0 10.0

(2)  
A substance is also a border controlled drug if the substance (the drug analogue ) is, in relation to a border controlled drug listed in subsection (1) (or a stereoisomer, a structural isomer (with the same constituent groups) or an alkaloid of such a border controlled drug):


(a) a stereoisomer; or


(b) a structural isomer having the same constituent groups; or


(c) an alkaloid; or


(d) a structural modification obtained by the addition of one or more of the following groups:


(i) alkoxy, cyclic diether, acyl, acyloxy, mono-animo or dialkylamino groups with up to 6 carbon atoms in any alkyl residue;

(ii) alkyl, alkenyl or alkynyl groups with up to 6 carbon atoms in the group, where the group is attached to oxygen (for example, an ester or an ether group), nitrogen, sulphur or carbon;

(iii) halogen, hydroxy, nitro or amino groups; or


(e) a structural modification obtained in one or more of the following ways:


(i) by the replacement of up to 2 carbocyclic or heterocyclic ring structures with different carbocyclic or heterocyclic ring structures;

(ii) by the addition of hydrogen atoms to one or more unsaturated bonds;

(iii) by the replacement of one or more of the groups specified in paragraph (d) with another such group or groups;

(iv) by the conversion of a carboxyl or an ester group into an amide group; or


(f) otherwise a homologue, analogue, chemical derivative or substance substantially similar in chemical structure;

however obtained, except where the drug analogue is separately listed in subsection (1).

(3)  
The marketable quantity for a drug analogue described in subsection (2) is:


(a) unless paragraph (b) applies - the marketable quantity specified in the table in subsection (1) for the border controlled drug to which the drug analogue relates (whether directly or indirectly); or


(b) if the drug analogue relates to more than one border controlled drug listed in the table in subsection (1) - the smallest marketable quantity specified in the table in subsection (1) for any of those border controlled drugs.

(4)  
The commercial quantity for a drug analogue described in subsection (2) is:


(a) unless paragraph (b) applies - the commercial quantity specified in the table in subsection (1) for the border controlled drug to which the drug analogue relates (whether directly or indirectly); or


(b) if the drug analogue relates to more than one border controlled drug listed in the table in subsection (1) - the smallest commercial quantity specified in the table in subsection (1) for any of those border controlled drugs.




This information is provided by CCH Australia Limited Link opens in new window. View the disclaimer and notice of copyright.